- 1 سال پیش
- 38
- 09:00
5th Case: Stable ASCVD
Daily cardiology
0
توضیحات
Low dose Rivaroxaban in SIHD, COMPASS trial
کاربر شنوتو
اولین نفر کامنت بزار
- 37
- 1 سال پیش
OAC choice in patients with obesity or low body weights, any role for DOACs?
OAC choice in patients with obesity or low body we...
09:33
- 37
- 1 سال پیش
09:33
- 39
- 1 سال پیش
OAC of choice in patients with artificial heart valves
OAC of choice in patients with artificial heart va...
11:30
- 39
- 1 سال پیش
11:30
- 39
- 1 سال پیش
Anticoagulation of choice in patients with cancer, the importance of DDI
Anticoagulation of choice in patients with cancer,...
12:58
- 39
- 1 سال پیش
12:58
- 43
- 1 سال پیش
Antithrombotic regimen of choice in patients with AF undergoing elective PCI
Antithrombotic regimen of choice in patients with ...
12:57
- 43
- 1 سال پیش
12:57
Endocrinologist Perspective on SGLT2 inhibitors
Endocrinologist Perspective on SGLT2 inhibitors
26:51
- 38
- 1 سال پیش
26:51
Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
Role of SGLT2 inhibitors in HF patients from two p...
09:36
- 35
- 1 سال پیش
09:36
Multidisciplinary approach to CVD Prevention
Multidisciplinary approach to CVD Prevention
02:06:19
- 74
- 1 سال پیش
02:06:19
- 26
- 1 سال پیش
A brief talk on DM medication challenges in patients with CVD
A brief talk on DM medication challenges in patien...
55:23
- 26
- 1 سال پیش
55:23
- 105
- 1 سال پیش
A brief talk on DM management in patients with CVD
A brief talk on DM management in patients with CVD
51:15
- 105
- 1 سال پیش
51:15
تمامی حقوق این وبسایت متعلق به شنوتو است